Ernexa Therapeutics Inc. EFFECT, filed Mar 20, 2023: primary_doc.xml
| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | March 20, 2023 |
| Accession Number: | 0001140361-23-012421 | ||||||
| Submission Type: | POS AM | ||||||
| |||||||